Send feedback

AR p.Ala159Thr

c.475G>A · rs370215797 · VCV492777

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.1491 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0219%, nfe)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
androgen insensitivity syndrome

Computational evidence

Protein change
AlphaMissense0.1491likely benign
REVEL0.75pathogenic-leaning
SaProtLLR -6.55tolerated
⇒ REVEL calls this damaging; AlphaMissense and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.6, phastCons 1
Overall
CADD26.9PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0219% European (non-Finnish) · 194/884,753 alleles
Filtering AF 0.0194% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0184%
Overall 0.0181% 215/1,189,197 alleles · ultra-rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0341% 2,928
European (non-Finnish)grpmax 0.0219% 4,561
Admixed American 0.00468% 21,369
African / African-American 0.00354% 28,274
Finnishnot grpmax-eligible 0.00223% 44,871

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AR
Protein
p.Ala159Thr
Coding
c.475G>A
MANE Select
NM_000044
dbSNP
rs370215797
Type
single nucleotide variant
Location
chrX:67545621 (GRCh38)
Structure
AlphaFold pLDDT 58.85 · 95 PDB
Residue 159
the 'interaction with znf318' region; the 'modulating' region; the 'disordered' region
Full AR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ar-p-ala159thr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown